Viva Biotech's market value is the price at which a share of Viva Biotech trades on a public exchange. It measures the collective expectations of Viva Biotech Holdings investors about its performance. Viva Biotech is trading at 0.25 as of the 28th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.25. With this module, you can estimate the performance of a buy and hold strategy of Viva Biotech Holdings and determine expected loss or profit from investing in Viva Biotech over a given investment horizon. Check out Viva Biotech Correlation, Viva Biotech Volatility and Viva Biotech Alpha and Beta module to complement your research on Viva Biotech.
Please note, there is a significant difference between Viva Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viva Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viva Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Viva Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Viva Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Viva Biotech.
0.00
07/01/2025
No Change 0.00
0.0
In 5 months and 30 days
12/28/2025
0.00
If you would invest 0.00 in Viva Biotech on July 1, 2025 and sell it all today you would earn a total of 0.00 from holding Viva Biotech Holdings or generate 0.0% return on investment in Viva Biotech over 180 days. Viva Biotech is related to or competes with Basilea Pharmaceutica, Sosei Group, GenSight Biologics, MedinCell, CellaVision, PureTech Health, and Valneva SE. Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology ... More
Viva Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Viva Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Viva Biotech Holdings upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viva Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Viva Biotech's standard deviation. In reality, there are many statistical measures that can use Viva Biotech historical prices to predict the future Viva Biotech's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Viva Biotech. Your research has to be compared to or analyzed against Viva Biotech's peers to derive any actionable benefits. When done correctly, Viva Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Viva Biotech Holdings.
Viva Biotech Holdings Backtested Returns
At this point, Viva Biotech is out of control. Viva Biotech Holdings owns Efficiency Ratio (i.e., Sharpe Ratio) of close to zero, which indicates the firm had a close to zero % return per unit of risk over the last 3 months. We have found eighteen technical indicators for Viva Biotech Holdings, which you can use to evaluate the volatility of the company. Please validate Viva Biotech's Coefficient Of Variation of 12580.9, risk adjusted performance of 0.0146, and Variance of 56.93 to confirm if the risk estimate we provide is consistent with the expected return of 0.0609%. The entity has a beta of 0.12, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Viva Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Viva Biotech is expected to be smaller as well. Viva Biotech Holdings right now has a risk of 7.6%. Please validate Viva Biotech variance, as well as the relationship between the skewness and relative strength index , to decide if Viva Biotech will be following its existing price patterns.
Auto-correlation
-0.61
Very good reverse predictability
Viva Biotech Holdings has very good reverse predictability. Overlapping area represents the amount of predictability between Viva Biotech time series from 1st of July 2025 to 29th of September 2025 and 29th of September 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Viva Biotech Holdings price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Viva Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.61
Spearman Rank Test
-0.86
Residual Average
0.0
Price Variance
0.0
Viva Biotech Holdings lagged returns against current returns
Autocorrelation, which is Viva Biotech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Viva Biotech's pink sheet expected returns. We can calculate the autocorrelation of Viva Biotech returns to help us make a trade decision. For example, suppose you find that Viva Biotech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Viva Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Viva Biotech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Viva Biotech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Viva Biotech pink sheet over time.
Current vs Lagged Prices
Timeline
Viva Biotech Lagged Returns
When evaluating Viva Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Viva Biotech pink sheet have on its future price. Viva Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Viva Biotech autocorrelation shows the relationship between Viva Biotech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Viva Biotech Holdings.
Viva Biotech financial ratios help investors to determine whether Viva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viva with respect to the benefits of owning Viva Biotech security.